亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Subtype-specific KRAS mutations in advanced lung adenocarcinoma: A retrospective study of patients treated with platinum-based chemotherapy

克拉斯 腺癌 医学 肿瘤科 内科学 化疗 肺癌 队列 回顾性队列研究 阶段(地层学) 临床意义 癌症 生物 结直肠癌 古生物学
作者
Mihály Cserepes,Gyula Ostoros,Zoltán Lohinai,Erzsébet Rásó,Tamás Barbai,József Tímár,Anita Rózsás,Judit Moldvay,Ilona Kovalszky,Katalin Fábián,Márton Gyulai,Bahil Ghanim,Viktória László,Thomas Klikovits,Mir Alireza Hoda,Michael Grusch,Walter Berger,Walter Klepetko,Balázs Hegedűs,Balázs Döme
出处
期刊:European Journal of Cancer [Elsevier BV]
卷期号:50 (10): 1819-1828 被引量:70
标识
DOI:10.1016/j.ejca.2014.04.001
摘要

Abstract

Background

Platinum-based chemotherapy is the most common treatment in advanced-stage lung adenocarcinoma. Because the clinical significance of KRAS mutational status in this setting has not yet been clearly determined, a mutation subtype-specific analysis was performed in the so far largest cohort of Caucasian patients with KRAS mutant advanced-stage lung adenocarcinoma treated with platinum-based chemotherapy.

Methods

505 Caucasian stage III–IV lung adenocarcinoma patients with known amino acid substitution-specific KRAS mutational status and treated with platinum-based chemotherapy were included. The correlations of subtype-specific KRAS mutations with smoking status, progression-free and overall survival (PFS and OS, respectively) and therapeutic response were analysed.

Results

Among 338 KRAS wild-type, 147 codon 12 mutant and 20 codon 13 mutant patients, there were no mutation-related significant differences in PFS or OS (P values were 0.534 and 0.917, respectively). Eastern Cooperative Oncology Group (ECOG) status and clinical stage were significant independent prognostic factors. KRAS mutation showed a significant correlation with smoking status (P=0.018). Importantly, however, G12V KRAS mutant patients were significantly more frequent among never-smokers than all other codon 12 KRAS mutant (G12x) subtypes (P=0.016). Furthermore, this subgroup tended to have a higher response rate (66% versus 47%; P=0.077). A modestly longer median PFS was also found in the G12V mutant cohort (233days; versus 175days in the G12x group; P=0.145).

Conclusions

While KRAS mutation status per se is neither prognostic nor predictive in stage III–IV lung adenocarcinoma, subtype-specific analysis may indeed identify clinically relevant subgroups of patients that may ultimately influence treatment decisions.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
小刘完成签到,获得积分10
刚刚
6秒前
三笠完成签到,获得积分10
8秒前
传奇3应助Liiiiiiiiii采纳,获得10
10秒前
gt完成签到 ,获得积分10
20秒前
22秒前
文静栾完成签到 ,获得积分10
24秒前
芝麻关注了科研通微信公众号
37秒前
42秒前
所所应助徐悦月采纳,获得10
44秒前
44秒前
核桃发布了新的文献求助10
46秒前
51秒前
芝麻发布了新的文献求助10
52秒前
昏睡的沛柔完成签到 ,获得积分10
54秒前
Aliya完成签到 ,获得积分10
1分钟前
酷波er应助科研通管家采纳,获得10
1分钟前
1分钟前
1分钟前
1分钟前
李李发布了新的文献求助10
1分钟前
bksqc发布了新的文献求助10
1分钟前
要文献啊完成签到 ,获得积分10
1分钟前
1分钟前
WUHUIWEN完成签到,获得积分10
1分钟前
Liiiiiiiiii发布了新的文献求助10
1分钟前
1分钟前
1分钟前
尊敬夜南发布了新的文献求助10
1分钟前
韦雪莲完成签到 ,获得积分10
2分钟前
wz完成签到,获得积分10
2分钟前
2分钟前
Liiiiiiiiii完成签到,获得积分10
2分钟前
杜德爽发布了新的文献求助10
2分钟前
好好搞科研完成签到 ,获得积分10
2分钟前
2分钟前
热情的寄瑶完成签到 ,获得积分10
2分钟前
yanglinhai完成签到 ,获得积分10
2分钟前
饱满含玉完成签到,获得积分10
2分钟前
2分钟前
高分求助中
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3990031
求助须知:如何正确求助?哪些是违规求助? 3532108
关于积分的说明 11256334
捐赠科研通 3270943
什么是DOI,文献DOI怎么找? 1805146
邀请新用户注册赠送积分活动 882270
科研通“疑难数据库(出版商)”最低求助积分说明 809228